Navigation Links
Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
Date:10/23/2008

HUYA has previously received positive pre-IND comments from the FDA Oncology Division for HBI-8000, including its willingness to accept both preclinical and clinical data generated in China as supportive information for the opening of a US IND and initiation of a Phase I trial. Both a Phase II/III lymphoma trial in China and a Phase I solid tumor/lymphoma trial in the US are planned for early 2009.

Preclinical Profile and Clinical Results

Chidamide/HBI-8000 is an orally bioavailable, low nanomolar inhibitor of cancer-associated HDACs and is one of the most potent inhibitors in the benzamide class. It selectively inhibits tumor cell growth, relative to normal cells, with a therapeutic index of over 20-fold.

Patients received escalating oral doses of 5 to 50 mg Chidamide/HBI-8000 either two or three times per week for four weeks, followed by a two week drug-free period for up to six cycles. PK parameters indicated significant exposure and this was validated by biomarker activity levels comparable to, but lasting longer than, most HDAC inhibitors. Chidamide/HBI-8000 produced significant activity in this early stage trial, with five out of twenty-five evaluable subjects experiencing a partial response and eleven with stable disease. The only dose-limiting toxicities (DLTs) were gastrointestinal in nature. Additional DLTs seen with other HDAC inhibitors, such as bone marrow suppression, fatigue and QTc prolongation were not observed with Chidamide/HBI-8000, supporting a best in class safety profile.

Results will be presented by Michael J. Newman, PhD, Executive Vice President, Oncology, HUYA Bioscience International at the Cambridge Healthtech Institute's annual conference on HDAC inhibitors, Thursday, October 23.

About HDACs and HDAC inhibitors

HDAC inhibitors, a new class of cancer drugs, work by controlling how tightly DNA is wound around accessory proteins, histones. By deacetylating (removing an acetyl group from) histones,
'/>"/>

SOURCE HUYA Bioscience International; Chipscreen Biosciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014  Particle Sciences, Inc ... has developed and manufactured a new innovative vaginal ... Research and Development arm of Exeltis Pharmaceuticals.  According ... Project Management at Particle Sciences, "This vaginal ring ... our material sciences and modeling expertise.  We are ...
(Date:11/21/2014)... and VIENNA, Va. , ... in-home care provider that operates in Southern ... leading provider of remote caregiving technology. Alta will be ... existing client receiving homecare services. Logo - ... technology is the key to providing the kind of ...
(Date:11/21/2014)... , Nov. 21, 2014  Heated dialogue in recent ... – from cancer treatments to Gilead,s new hepatitis C ... around the world questioning what it means to put ... And while drug pricing is one ... – from both a general business and ethical standpoint ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5
... , SANTA MONICA, Calif., Jan. 11 Derycz Scientific (OTC ... of facilitating the flow of information from content publishers to enterprise ... January 10, 2010, on the website of DDN ( ... & CEO Peter Derycz, is titled "Speeding the Path to FDA ...
... , , , SEATTLE, Jan. 11 Cell Therapeutics, Inc. ... JP Morgan Healthcare Conference in San Francisco. The conference will be held ... on Thursday, January 14, 2010, 2:00 PM Pacific Time. The conference will ... The webcast can be accessed at www.celltherapeutics.com . , , ...
Cached Medicine Technology:Derycz Scientific Featured In DDN (Drug Discovery News) 2Derycz Scientific Featured In DDN (Drug Discovery News) 3Cell Therapeutics, Inc. (CTI) to Present at the 28th Annual JP Morgan Healthcare Conference 2
(Date:11/24/2014)... Recently, SweetDressy.com, a well-known dress supplier and ... of 2014 Evening Dresses. All these fresh items are ... marketing manager, the special offer is valid until Dec. ... Sweetdressy.com has been working well in the fashion industry ... designs. Their new dresses may be the best products ...
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 SafeHandles™ ... episode of Innovations with Ed Begley Jr, airing via ... was created to provide a passive, non-invasive, replaceable, and ... how SafeHandles™ incorporates custom-fit shrinkable sleeves and adhesives to ... , “At the core of SafeHandles is the ...
(Date:11/23/2014)... The clinical trial report, "Aspergillosis Global ... the Aspergillosis clinical trial scenario. This report provides ... trials on Aspergillosis. It includes an overview of ... per the site of trial conduction across the ... disease clinical trials by their phase, trial status, ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot ... be providing an 8 year warranty on its selected hot ... went up due to the impending winter season, it was ... the premium service that the company provides. As a result, ... John Wood and Bradford hot water tanks. , “Every ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 23, 2014 ... the market such as its significance, programs and ... globally and Chinese suppliers major market gamers in ... company information, item specifications, prospective, manufacturing value, and ... statistical research, the evaluation symbolizes the globally and ...
Breaking Medicine News(10 mins):Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4
... Pro-lifers and "Truth Truck" to hold vigil at Casey,s home ... babies. , SCRANTON, Pa., Dec. 18 The following was ... Pennsylvania pro-lifers to hold vigil at Casey,s home; "A Vote ... Beginning this evening, December 18, pro-lifers from PA will hold ...
... New York, New YorkAn overwhelming majority88 percentof young adults ... Congress and the President to pass health reform legislation ... improve health care, according to a Commonwealth Fund survey ... July of 2009, found that nearly half45 percentor approximately ...
... behaviors, beyond anorexia, can affect women. Indeed, some 10 ... and attitudes according to new study from the Universit ... published in the International Journal of Eating Disorders. ... a professor at the Universit de Montral Department of ...
... issue of an aging-focused newsletter deals with two pressing ... reform from the perspective of older minority adults. ... Gerontological Society of America (GSA), the country,s largest interdisciplinary ... this issue was provided by sanofi-aventis. Based on ...
... system turns off antibodies that could block HIV, study finds ... identified the cause of a major hurdle in efforts to ... scientists found that the immune system can produce B cells ... virus that causes AIDS. But the immune system mistakenly perceives ...
... Dec. 18 On Jan. 1, 2010, a new century begins ... an invitation to the nation to experience Scouting like never before. ... of Roses Parade, with a float entitled: "Celebrating the Adventure, Continuing ... time for our organization," said Bob Mazzuca, Chief Scout Executive of ...
Cached Medicine News:Health News:New Commonwealth Fund survey of young adults finds wide majority support health reform 2Health News:New Commonwealth Fund survey of young adults finds wide majority support health reform 3Health News:Disordered eating may affect 10 to 15 percent of women 2Health News:Boy Scouts of America Launch 100th Year With Scouting Experience of a Lifetime 2Health News:Boy Scouts of America Launch 100th Year With Scouting Experience of a Lifetime 3
Colloidal Gold Conjugated, Protein A - 12 OD...
Polyester ribbon impregnated with conjugated Protein G - .13 OD per sq. cm....
Colloidal Gold Sol, 30 nm 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
... empowering alternative to bulky biometry devices that ... PalmScan AP2000 is the world's only battery-operated, ... on the market today. Each unit weighs ... to perform multiple functions, namely: auto data ...
Medicine Products: